(OTCBB:WLSI) Wellstar International, Inc.

Turning Pennies into dollars: (OTCBB:WLSI) Wellstar International, Inc.



Are you a public company looking for exposure?

Contact RealPennies.com - 212-662-2147



For more info: http://www.realpennies.com/otc/wlsi

Wellstar/TMI Announces Pending Pressure Ulcer Study on Leg and Foot Ulcers

(OTCBB:WLSI) Wellstar International, Inc.

HOLLAND, OH-Jan 14, 2009 - Wellstar International, Inc. , a provider of specialized diagnostic software and equipment, announced recently that its wholly owned subsidiary, Trillennium Medical Imaging , has begun negotiations for a pressure ulcer study focused on ulcers caused by diabetic foot and venous legs. The Company is currently in talks with several major teaching and research universities, the goal of which is to secure a clinical partner for this study. Wellstar anticipates that the study could start as early as March 2009.

In the U.S. alone, approximately 1.5 million adults are treated each year for pressure ulcers with associated health care costs of over $5 billion. Regrettably, more than 65,000 patients die each year from complications related to these ulcers. Pressure ulcers represent one of four of the most common and costly deficiencies found in long-term care facilities.

A diabetic foot ulcer is a sore or wound that often occurs in people with diabetes; these ulcers may be difficult to heal, susceptible to infection and may lead to amputation of the affected toe, foot or leg if not treated. Over 850,000 chronic diabetic ulcers are diagnosed in the U.S. each year. Approximately 3 million diabetic patients will develop an ulcer and 25% of these patients will have a foot amputated.

Profile for Wellstar International, Inc.

Wellstar International, Inc., through its subsidiary, Trillennium Medical Imaging, Inc., engages in developing and licensing the use of advanced thermal imaging technology in the consumer healthcare and veterinary markets in the United States. The company primarily provides thermal imaging equipment and related software, which offer an adjunctive diagnostic screening procedure for early breast cancer detection; differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; detection of pressure ulcers; deep tissue injuries; and bed sores, as well as orthopedic applications. It markets its products to university... Detailed WLSI Company Description...

LAST $0.0024 USD



SAFE HARBOR STATEMENT

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements, which are other than statements of historical facts. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, risks set forth in documents filed by the Company from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by, or on behalf of, the Company, are expressly qualified by these cautionary statements and any other cautionary statements which may



Realpennies.com



Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on

http://www.realpennies.com/start.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. This may contain forward-looking statements and are not guarantees of performance. Reproduction of this without written permission is prohibited.

RealPennies.com

Phone: 212-662-2147

info [at] realpennies.com